Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Protein digestion and absorption,0.0005237059682618533,4.398307952622673,33.227369998241166,"['COL27A1', 'COL5A1', 'COL11A1', 'COL12A1', 'COL23A1', 'COL21A1', 'PRCP', 'COL9A2', 'SLC38A2']",0.13302131593851071,0,0,9
2,Antigen processing and presentation,0.007570905166115938,3.864527629233512,18.872199030774297,"['PDIA3', 'CTSL', 'PSME2', 'HSPA2', 'CALR', 'HLA-E']",0.9615049560967242,0,0,6
3,Platelet activation,0.02745104473526685,2.3681519357195033,8.51433755380715,"['VASP', 'RAP1A', 'PPP1R12A', 'TBXAS1', 'TLN1', 'ADCY8', 'RASGRP1', 'ACTG1']",0.9923797351506365,0,0,8
4,Glycerolipid metabolism,0.03285434159445827,3.0359477124183005,10.369799708140963,"['MBOAT2', 'DGKZ', 'LPIN2', 'PLPP1', 'AGPAT3']",0.9923797351506365,0,0,5
5,Purine metabolism,0.03742035956868511,2.0976347337725456,6.8918635556614145,"['ENTPD5', 'IMPDH2', 'ENPP4', 'AK4', 'AMPD2', 'NUDT16', 'ADCY8', 'PDE8A', 'AK9']",0.9923797351506365,0,0,9
6,Glycerophospholipid metabolism,0.038474593643091144,2.3566999610844466,7.677556174306285,"['MBOAT2', 'PNPLA6', 'GPCPD1', 'DGKZ', 'LPIN2', 'PLPP1', 'AGPAT3']",0.9923797351506365,0,0,7
7,Proteoglycans in cancer,0.06939225671527315,1.7211011399466407,4.591863406278219,"['FZD3', 'MRAS', 'PPP1R12A', 'CTSL', 'FZD9', 'HSPB2', 'PLCE1', 'FLNA', 'IQGAP1', 'HSPG2', 'ACTG1']",0.9923797351506365,0,0,11
8,Protein export,0.0780709840404917,3.271859296482412,8.343688843292023,"['SRP72', 'SEC62', 'SEC11A']",0.9923797351506365,0,0,3
9,Hippo signaling pathway,0.07890109532032284,1.7903091832025841,4.546597891569422,"['FZD3', 'PPP2R1B', 'DCHS2', 'PPP2R2B', 'FZD9', 'CTNNA1', 'CTNNA2', 'TEAD1', 'ACTG1']",0.9923797351506365,0,0,9
10,Arachidonic acid metabolism,0.08643372326370029,3.1158171811438145,7.628696255968572,"['CBR1', 'TBXAS1', 'PTGDS']",0.9923797351506365,0,0,3
11,Thyroid hormone signaling pathway,0.08732765620478963,1.8223536036036037,4.443058582619665,"['NOTCH2', 'NCOA1', 'MED13', 'MED24', 'PLCE1', 'PFKP', 'PLCD1', 'ACTG1']",0.9923797351506365,0,0,8
12,Phagosome,0.1009702469649614,1.8430484162620127,4.225979880922597,"['DYNC1LI2', 'CTSL', 'SFTPD', 'CALR', 'ATP6V0E2', 'ACTG1', 'HLA-E']",0.9923797351506365,0,0,7
13,Lysosome,0.1029894795417519,1.748918918918919,3.9755173274485234,"['SCARB2', 'CTSL', 'AP1B1', 'SLC17A5', 'TPP1', 'AP3B1', 'ARSG', 'AP3B2']",0.9923797351506365,0,0,8
14,Cysteine and methionine metabolism,0.1045347881420449,2.3589697079629968,5.327108812634518,"['AHCY', 'MTR', 'SDSL', 'CDO1']",0.9923797351506365,0,0,4
15,Selenocompound metabolism,0.10938355894122608,3.9619945272119184,8.76747662805338,"['TXNRD1', 'MTR']",0.9923797351506365,0,0,2
16,Adherens junction,0.12967344576654902,1.9486794717887155,3.980637601180956,"['CTNNA1', 'IQGAP1', 'CTNNA2', 'NECTIN3', 'ACTG1']",0.9923797351506365,0,0,5
17,Focal adhesion,0.1330433151847462,1.5397469563141561,3.1057936000889486,"['VASP', 'PDGFRB', 'RAP1A', 'PPP1R12A', 'CAPN2', 'FLNA', 'COL9A2', 'TLN1', 'DOCK1', 'ACTG1']",0.9923797351506365,0,0,10
18,Rap1 signaling pathway,0.13712536281477403,1.5288609695389357,3.037632269480941,"['VASP', 'ENAH', 'PDGFRB', 'MRAS', 'RAP1A', 'ANGPT2', 'PLCE1', 'TLN1', 'ADCY8', 'ACTG1']",0.9923797351506365,0,0,10
19,cGMP-PKG signaling pathway,0.14348998942631205,1.603396974956608,3.112979203027858,"['VASP', 'PPP3CB', 'PPP1R12A', 'IRS1', 'ADORA1', 'KCNMB3', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,8
20,"Glycine, serine and threonine metabolism",0.14355057341524932,2.4222966685278244,4.701842253998795,"['GLDC', 'CHDH', 'SDSL']",0.9923797351506365,0,0,3
21,Regulation of actin cytoskeleton,0.1585028322754062,1.4766376546037563,2.7199411860936205,"['CYFIP2', 'ENAH', 'PDGFRB', 'MRAS', 'PPP1R12A', 'SPATA13', 'IQGAP1', 'DOCK1', 'ARHGEF6', 'ACTG1']",0.9923797351506365,0,0,10
22,Notch signaling pathway,0.1765414446421589,1.8961190545666764,3.2882489369581327,"['TLE4', 'NOTCH2', 'TLE2', 'DTX4']",0.9923797351506365,0,0,4
23,Bacterial invasion of epithelial cells,0.186408454039827,1.7040441176470589,2.8624789094761485,"['SEPTIN2', 'CTNNA1', 'CTNNA2', 'DOCK1', 'ACTG1']",0.9923797351506365,0,0,5
24,Leukocyte transendothelial migration,0.194061050351986,1.677698771816419,2.7507255077669024,"['VASP', 'RAP1A', 'CTNNA1', 'CTNNA2', 'ACTG1']",0.9923797351506365,0,0,5
25,Estrogen signaling pathway,0.19726626477275377,1.5770962638432517,2.5599440196571406,"['NCOA1', 'KCNJ9', 'GPER1', 'HSPA2', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,6
26,Gastric acid secretion,0.20353995779409967,1.7796192302424325,2.8329632895390997,"['KCNJ10', 'KCNJ16', 'ADCY8', 'ACTG1']",0.9923797351506365,0,0,4
27,Ribosome,0.2076832709416367,1.4430422157694884,2.268088753324388,"['RPL41', 'RPL23', 'RPS20', 'RPL23A', 'RPL39', 'MRPS6', 'RPS24', 'RPS12']",0.9923797351506365,0,0,8
28,RNA degradation,0.2096849356448843,1.6273673648563902,2.5421905966917206,"['BTG1', 'PNPT1', 'NUDT16', 'PABPC1L', 'PFKP']",0.9923797351506365,0,0,5
29,Morphine addiction,0.21764574172935847,1.6033119130004942,2.4448688131760985,"['GRK3', 'KCNJ9', 'ADORA1', 'ADCY8', 'PDE8A']",0.9923797351506365,0,0,5
30,Glutathione metabolism,0.22131805410317126,1.9225539462015961,2.8995082955255276,"['ODC1', 'GSR', 'PRDX6']",0.9923797351506365,0,0,3
31,mTOR signaling pathway,0.22527756176198285,1.407802964254577,2.098220550720096,"['RPS6KA3', 'FZD3', 'IRS1', 'CAB39L', 'RRAGD', 'FZD9', 'FNIP1', 'LPIN2']",0.9923797351506365,0,0,8
32,Mismatch repair,0.23543049906052405,2.292378102446752,3.3155570669185996,"['MSH2', 'MLH3']",0.9923797351506365,0,0,2
33,Taurine and hypotaurine metabolism,0.23655953161537643,4.352921535893155,6.274977473681298,['CDO1'],0.9923797351506365,0,0,1
34,Fc gamma R-mediated phagocytosis,0.24205986646679775,1.5352112676056338,2.1778049569639624,"['VASP', 'MARCKSL1', 'INPP5D', 'DOCK1', 'PLPP1']",0.9923797351506365,0,0,5
35,Cortisol synthesis and secretion,0.2449246906789958,1.815466219988833,2.554006049101084,"['ADCY8', 'PDE8A', 'CREB5']",0.9923797351506365,0,0,3
36,Regulation of lipolysis in adipocytes,0.2449246906789958,1.815466219988833,2.554006049101084,"['IRS1', 'ADORA1', 'ADCY8']",0.9923797351506365,0,0,3
37,Butanoate metabolism,0.25196501207431715,2.177591973244147,3.001734411041834,"['OXCT1', 'L2HGDH']",0.9923797351506365,0,0,2
38,Protein processing in endoplasmic reticulum,0.2603436538676041,1.3177188021667292,1.773323734763051,"['PDIA3', 'PRKN', 'FBXO2', 'DNAJB11', 'CAPN2', 'HSPA2', 'CALR', 'SEC62', 'RAD23B']",0.9923797351506365,0,0,9
39,Long-term potentiation,0.2606332991276251,1.5847467968273337,2.130915270032678,"['RPS6KA3', 'PPP3CB', 'RAP1A', 'ADCY8']",0.9923797351506365,0,0,4
40,Synaptic vesicle cycle,0.2606332991276251,1.5847467968273337,2.130915270032678,"['RIMS1', 'SLC6A9', 'AP2A1', 'ATP6V0E2']",0.9923797351506365,0,0,4
41,Glucagon signaling pathway,0.2842012887505522,1.433657673595754,1.803645334666017,"['PYGB', 'PPP3CB', 'SIK2', 'PFKP', 'CREB5']",0.9923797351506365,0,0,5
42,AMPK signaling pathway,0.28464974637945795,1.3766081871345028,1.729702425445945,"['PPP2R1B', 'IRS1', 'CAB39L', 'PPP2R2B', 'PFKP', 'CREB5']",0.9923797351506365,0,0,6
43,Choline metabolism in cancer,0.29279928916422904,1.4149296082069192,1.7379126533496527,"['PDGFRB', 'SLC44A2', 'GPCPD1', 'DGKZ', 'PLPP1']",0.9923797351506365,0,0,5
44,Pyrimidine metabolism,0.2931259871375506,1.6334170854271357,2.0044523044653366,"['ENTPD5', 'UPP2', 'AK9']",0.9923797351506365,0,0,3
45,Insulin secretion,0.30024305132122786,1.4768513252189739,1.7768928138009732,"['ABCC8', 'KCNMB3', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,4
46,Renin-angiotensin system,0.3022682481050209,3.1087526830431673,3.719437356759432,['PRCP'],0.9923797351506365,0,0,1
47,Synthesis and degradation of ketone bodies,0.3022682481050209,3.1087526830431673,3.719437356759432,['OXCT1'],0.9923797351506365,0,0,1
48,Nucleotide excision repair,0.30529508601324007,1.593455080279446,1.890596966674752,"['DDB1', 'GTF2H3', 'RAD23B']",0.9923797351506365,0,0,3
49,Glyoxylate and dicarboxylate metabolism,0.31804302622845404,1.814102564102564,2.0781789396029526,"['GLDC', 'ACO1']",0.9923797351506365,0,0,2
50,Tight junction,0.31847919264619273,1.2819164765400257,1.4667664420870448,"['VASP', 'IGSF5', 'RAP1A', 'PPP2R1B', 'PPP2R2B', 'AMOTL2', 'ACTG1']",0.9923797351506365,0,0,7
51,Longevity regulating pathway,0.3275829815427478,1.3446415603278348,1.50063864124667,"['IRS1', 'SESN1', 'HSPA2', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,5
52,Basal cell carcinoma,0.329679689923938,1.5191071637256048,1.685652552134836,"['FZD3', 'FZD9', 'GLI1']",0.9923797351506365,0,0,3
53,Cushing syndrome,0.33118177687362194,1.2942294229422941,1.430237248587897,"['FZD3', 'RAP1A', 'FZD9', 'ADCY8', 'PDE8A', 'CREB5']",0.9923797351506365,0,0,6
54,Phototransduction,0.3329737206208149,2.719949916527546,2.9911063725641127,['GUCA1B'],0.9923797351506365,0,0,1
55,Thiamine metabolism,0.3329737206208149,2.719949916527546,2.9911063725641127,['AK4'],0.9923797351506365,0,0,1
56,Phosphatidylinositol signaling system,0.33635147538677246,1.328141012502562,1.447140598526623,"['INPP5D', 'PLCE1', 'DGKZ', 'PLCD1', 'IP6K2']",0.9923797351506365,0,0,5
57,Ubiquitin mediated proteolysis,0.3471355013614107,1.2398442534172391,1.3118049148352264,"['DDB1', 'PRKN', 'FBXW7', 'FBXO2', 'CDC27', 'KLHL13', 'RHOBTB2']",0.9923797351506365,0,0,7
58,Thermogenesis,0.34934918926866315,1.1844141488577744,1.2456285980145225,"['RPS6KA3', 'SMARCC2', 'UQCRB', 'CPT2', 'NDUFAF2', 'UQCR10', 'ADCY8', 'ACTG1', 'ATP5ME', 'CREB5']",0.9923797351506365,0,0,10
59,Circadian rhythm,0.3506348303524559,1.6742989452019552,1.7546819813755636,"['CRY2', 'RORA']",0.9923797351506365,0,0,2
60,Phospholipase D signaling pathway,0.35481211523758965,1.2566045066045066,1.3020519740964778,"['PDGFRB', 'MRAS', 'ADCY8', 'DGKZ', 'PLPP1', 'AGPAT3']",0.9923797351506365,0,0,6
61,Shigellosis,0.35524404218251476,1.1779202931745305,1.2190889406777412,"['RNF31', 'SEPTIN2', 'RRAGD', 'CAPN2', 'PLCE1', 'TLN1', 'DOCK1', 'SEPTIN7', 'PLCD1', 'ACTG1']",0.9923797351506365,0,0,10
62,Nitrogen metabolism,0.3623300710491144,2.417547764793174,2.4542937271482277,['CA12'],0.9923797351506365,0,0,1
63,Thyroid hormone synthesis,0.366187163306954,1.41970723181123,1.4262530775532931,"['GSR', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,3
64,Oocyte meiosis,0.37156914526427265,1.2659761579050224,1.2533421052755964,"['RPS6KA3', 'PPP3CB', 'PPP2R1B', 'CDC27', 'ADCY8']",0.9923797351506365,0,0,5
65,Glutamatergic synapse,0.3803861185961091,1.2513281174538782,1.209494267134754,"['GRK3', 'PPP3CB', 'DLGAP1', 'ADCY8', 'SLC38A2']",0.9923797351506365,0,0,5
66,MAPK signaling pathway,0.3864679393131527,1.1356785941309473,1.0796968688518067,"['PDGFRB', 'RPS6KA3', 'PPP3CB', 'MRAS', 'RAP1A', 'ANGPT2', 'FLNA', 'MAPT', 'HSPA2', 'RASGRP1', 'DUSP16']",0.9923797351506365,0,0,11
67,Allograft rejection,0.3903964817479052,2.1756260434056762,2.0463774008623106,['HLA-E'],0.9923797351506365,0,0,1
68,Graft-versus-host disease,0.3903964817479052,2.1756260434056762,2.0463774008623106,['HLA-E'],0.9923797351506365,0,0,1
69,DNA replication,0.4140191958401112,1.450613154960981,1.2792129686019935,"['RNASEH2C', 'MCM5']",0.9923797351506365,0,0,2
70,Autoimmune thyroid disease,0.4172295429260932,1.977690089543178,1.7287359810082092,['HLA-E'],0.9923797351506365,0,0,1
71,Arrhythmogenic right ventricular cardiomyopathy,0.4261239500762926,1.2800275889250172,1.091895549932738,"['CTNNA1', 'CTNNA2', 'ACTG1']",0.9923797351506365,0,0,3
72,Pyruvate metabolism,0.42939181849272723,1.4037112957169058,1.1866771012814257,"['ME2', 'ACYP1']",0.9923797351506365,0,0,2
73,Viral myocarditis,0.42939181849272723,1.4037112957169058,1.1866771012814257,"['ACTG1', 'HLA-E']",0.9923797351506365,0,0,2
74,Cell adhesion molecules,0.4309241353199664,1.208985831469053,1.0177523510354405,"['IGSF11', 'VCAN', 'NECTIN3', 'HLA-E']",0.9923797351506365,0,0,4
75,Epithelial cell signaling in Helicobacter pylori infection,0.4378904840481728,1.255315036722072,1.0366221305955998,"['IGSF5', 'ADAM10', 'ATP6V0E2']",0.9923797351506365,0,0,3
76,Tyrosine metabolism,0.4428833662308738,1.8127434613244295,1.4763867825509163,['FAH'],0.9923797351506365,0,0,1
77,Type II diabetes mellitus,0.44454822991753684,1.3597408026755853,1.102337417159068,"['IRS1', 'ABCC8']",0.9923797351506365,0,0,2
78,ECM-receptor interaction,0.4495645178248465,1.2315350336588604,0.9845825830436556,"['COL9A2', 'NPNT', 'HSPG2']",0.9923797351506365,0,0,3
79,RNA transport,0.4628730285123444,1.095769590061509,0.8440740535306915,"['CYFIP2', 'EIF1AY', 'NUP210', 'EIF3E', 'PABPC1L', 'AAAS', 'EIF3D']",0.9923797351506365,0,0,7
80,cAMP signaling pathway,0.4700212190097235,1.087858347386172,0.8213085085255583,"['RAP1A', 'PPP1R12A', 'ADORA1', 'PLCE1', 'GLI1', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,7
81,Vasopressin-regulated water reabsorption,0.4741708518337218,1.279559315364942,0.9547912630177771,"['DYNC1LI2', 'CREB5']",0.9923797351506365,0,0,2
82,Oxidative phosphorylation,0.48471800604599125,1.0986333927510399,0.7956171062175533,"['PPA2', 'UQCRB', 'UQCR10', 'ATP6V0E2', 'ATP5ME']",0.9923797351506365,0,0,5
83,Fat digestion and absorption,0.49085799838511135,1.5535416169806822,1.1055008391799668,['PLPP1'],0.9923797351506365,0,0,1
84,Rheumatoid arthritis,0.5028169277014164,1.2082868821999257,0.8307324361160229,"['CTSL', 'ATP6V0E2']",0.9923797351506365,0,0,2
85,Steroid biosynthesis,0.5132755892503575,1.449860879243183,0.9669736466857898,['TM7SF2'],0.9923797351506365,0,0,1
86,Arginine and proline metabolism,0.5167570413746787,1.1755400885835667,0.7760709407430278,"['ODC1', 'PYCR2']",0.9923797351506365,0,0,2
87,Sphingolipid metabolism,0.5167570413746787,1.1755400885835667,0.7760709407430278,"['DEGS2', 'PLPP1']",0.9923797351506365,0,0,2
88,Coronavirus disease,0.5262073117639818,1.0284171186363429,0.6603055106836534,"['RPL41', 'RPL23', 'RPS20', 'RPL23A', 'RPL39', 'RPS24', 'RPS12']",0.9923797351506365,0,0,7
89,Apoptosis,0.526469738674123,1.0454104718810602,0.6706950325332958,"['DFFA', 'CTSL', 'CAPN2', 'SEPTIN4', 'ACTG1']",0.9923797351506365,0,0,5
90,Vibrio cholerae infection,0.5304350532110851,1.1445168104207006,0.7256897582741116,"['ATP6V0E2', 'ACTG1']",0.9923797351506365,0,0,2
91,Dopaminergic synapse,0.534643907081038,1.0353741496598639,0.6483040255473358,"['PPP3CB', 'PPP2R1B', 'KCNJ9', 'PPP2R2B', 'CREB5']",0.9923797351506365,0,0,5
92,Collecting duct acid secretion,0.5347077003992767,1.3591402337228715,0.850869404856826,['ATP6V0E2'],0.9923797351506365,0,0,1
93,Folate biosynthesis,0.5347077003992767,1.3591402337228715,0.850869404856826,['CBR1'],0.9923797351506365,0,0,1
94,Type I diabetes mellitus,0.5347077003992767,1.3591402337228715,0.850869404856826,['HLA-E'],0.9923797351506365,0,0,1
95,Hepatocellular carcinoma,0.548402786337365,1.0111189413514996,0.6074249016653362,"['FZD3', 'SMARCC2', 'TXNRD1', 'FZD9', 'ARID2', 'ACTG1']",0.9923797351506365,0,0,6
96,Insulin resistance,0.5543153916752492,1.0230556652191078,0.6036247923138053,"['RPS6KA3', 'PYGB', 'IRS1', 'CREB5']",0.9923797351506365,0,0,4
97,One carbon pool by folate,0.5551975842957615,1.2790926053225964,0.7526580233318594,['MTR'],0.9923797351506365,0,0,1
98,Chemical carcinogenesis,0.5556868455424138,1.0032634032634034,0.5894677846430446,"['NOTCH2', 'RPS6KA3', 'CBR1', 'ADCY8', 'KPNA1', 'CREB5']",0.9923797351506365,0,0,6
99,Mineral absorption,0.5569898589845566,1.087123745819398,0.6361937801623009,"['HEPH', 'FTH1']",0.9923797351506365,0,0,2
100,"Valine, leucine and isoleucine degradation",0.5569898589845566,1.087123745819398,0.6361937801623009,"['OXCT1', 'IVD']",0.9923797351506365,0,0,2
101,Human T-cell leukemia virus 1 infection,0.5601542653319804,0.9944229518676498,0.576310919844835,"['PPP3CB', 'CDC27', 'CALR', 'TLN1', 'ADCY8', 'HLA-E', 'CREB5']",0.9923797351506365,0,0,7
102,Proteasome,0.5698612590742169,1.060526959784648,0.5964004364335769,"['PSMD6', 'PSME2']",0.9923797351506365,0,0,2
103,Renin secretion,0.5698612590742169,1.060526959784648,0.5964004364335769,"['PPP3CB', 'ADORA1']",0.9923797351506365,0,0,2
104,Inositol phosphate metabolism,0.5701594091719382,1.019001256281407,0.5725149444156314,"['INPP5D', 'PLCE1', 'PLCD1']",0.9923797351506365,0,0,3
105,Necroptosis,0.5720370542842049,0.9993828589061174,0.558206804393793,"['RNF31', 'PYGB', 'FTH1', 'CAPN2']",0.9923797351506365,0,0,4
106,Oxytocin signaling pathway,0.574503584358828,0.987929717341482,0.5475590012193571,"['PPP3CB', 'PPP1R12A', 'KCNJ9', 'ADCY8', 'ACTG1']",0.9923797351506365,0,0,5
107,Retinol metabolism,0.574786598317054,1.2079391578556855,0.6689040883143588,['ALDH1A1'],0.9923797351506365,0,0,1
108,Systemic lupus erythematosus,0.5935142873093203,1.1442755469642387,0.5969616783291682,['SNRPD1'],0.9923797351506365,0,0,1
109,Cell cycle,0.5978620105487675,0.9658463832960478,0.49682684322794496,"['STAG1', 'TFDP2', 'CDC27', 'MCM5']",0.9923797351506365,0,0,4
110,Chagas disease,0.6001039821023634,0.9731493287332184,0.4969409772912222,"['PPP2R1B', 'PPP2R2B', 'CALR']",0.9923797351506365,0,0,3
111,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.6001039821023634,0.9731493287332184,0.4969409772912222,"['ALK', 'PPP3CB', 'RASGRP1']",0.9923797351506365,0,0,3
112,Herpes simplex virus 1 infection,0.6020015040856421,0.9586286783542358,0.48649958244921426,"['ZNF441', 'PDIA3', 'ZNF583', 'ZNF891', 'ZNF44', 'HLA-E', 'ZNF718', 'ZNF81', 'ZNF605', 'CALR', 'ZNF621', 'ZNF433', 'ZNF763', 'ZNF135', 'ZNF564', 'ZNF641', 'ZNF442']",0.9923797351506365,0,0,17
113,Porphyrin and chlorophyll metabolism,0.6114184630820232,1.0869782971619366,0.534764704174666,['HEPH'],0.9923797351506365,0,0,1
114,Drug metabolism,0.6186104565774344,0.9659606094388703,0.4639310932587534,"['IMPDH2', 'UPP2']",0.9923797351506365,0,0,2
115,Pentose phosphate pathway,0.6285352800663072,1.035137928293187,0.4806798767395721,['PFKP'],0.9923797351506365,0,0,1
116,Hedgehog signaling pathway,0.6301133876665728,0.9448887596335611,0.43640206614817617,"['GRK3', 'GLI1']",0.9923797351506365,0,0,2
117,Human papillomavirus infection,0.6307318206127336,0.9317669309667563,0.4294276312235225,"['PDGFRB', 'NOTCH2', 'FZD3', 'PPP2R1B', 'PPP2R2B', 'FZD9', 'COL9A2', 'ATP6V0E2', 'HLA-E', 'CREB5']",0.9923797351506365,0,0,10
118,Melanogenesis,0.6378427180645332,0.9180409087691981,0.4128095335674184,"['FZD3', 'FZD9', 'ADCY8']",0.9923797351506365,0,0,3
119,Progesterone-mediated oocyte maturation,0.6378427180645332,0.9180409087691981,0.4128095335674184,"['RPS6KA3', 'CDC27', 'ADCY8']",0.9923797351506365,0,0,3
120,Wnt signaling pathway,0.6414330101136012,0.912576795424052,0.4052302072336681,"['TLE4', 'TLE2', 'FZD3', 'PPP3CB', 'FZD9']",0.9923797351506365,0,0,5
121,Aminoacyl-tRNA biosynthesis,0.6448993081704523,0.9880103202306875,0.43340167979141037,['YARS2'],0.9923797351506365,0,0,1
122,Galactose metabolism,0.6448993081704523,0.9880103202306875,0.43340167979141037,['PFKP'],0.9923797351506365,0,0,1
123,Metabolism of xenobiotics by cytochrome P450,0.6448993081704523,0.9880103202306875,0.43340167979141037,['CBR1'],0.9923797351506365,0,0,1
124,Sphingolipid signaling pathway,0.6543455882660861,0.895661800318273,0.3798677644916231,"['PPP2R1B', 'PPP2R2B', 'ADORA1', 'DEGS2']",0.9923797351506365,0,0,4
125,Biosynthesis of unsaturated fatty acids,0.6605436016997326,0.944980765043188,0.391876099520125,['ELOVL6'],0.9923797351506365,0,0,1
126,Fatty acid elongation,0.6605436016997326,0.944980765043188,0.391876099520125,['ELOVL6'],0.9923797351506365,0,0,1
127,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.6605436016997326,0.944980765043188,0.391876099520125,['PIGM'],0.9923797351506365,0,0,1
128,Inflammatory bowel disease,0.6605436016997326,0.944980765043188,0.391876099520125,['RORA'],0.9923797351506365,0,0,1
129,Ovarian steroidogenesis,0.6605436016997326,0.944980765043188,0.391876099520125,['ADCY8'],0.9923797351506365,0,0,1
130,Starch and sucrose metabolism,0.6605436016997326,0.944980765043188,0.391876099520125,['PYGB'],0.9923797351506365,0,0,1
131,Apelin signaling pathway,0.6619655032609241,0.8864539104232297,0.36569932221125767,"['MRAS', 'NRF1', 'ADCY8', 'KLF2']",0.9923797351506365,0,0,4
132,Gastric cancer,0.6619655032609241,0.8864539104232297,0.36569932221125767,"['FZD3', 'FZD9', 'CTNNA1', 'CTNNA2']",0.9923797351506365,0,0,4
133,B cell receptor signaling pathway,0.6629968872087662,0.8868336632311787,0.36447531873116956,"['PPP3CB', 'INPP5D']",0.9923797351506365,0,0,2
134,GnRH secretion,0.6629968872087662,0.8868336632311787,0.36447531873116956,"['KCNJ9', 'GPER1']",0.9923797351506365,0,0,2
135,p53 signaling pathway,0.6629968872087662,0.8868336632311787,0.36447531873116956,"['SESN1', 'PPM1D']",0.9923797351506365,0,0,2
136,Autophagy,0.668984468470407,0.8826262212201954,0.3548108292582833,"['MRAS', 'IRS1', 'CTSL', 'RRAGD', 'SNAP29']",0.9923797351506365,0,0,5
137,Mucin type O-glycan biosynthesis,0.6754997659832326,0.9055370061213133,0.35524440238196464,['GALNT8'],0.9923797351506365,0,0,1
138,PPAR signaling pathway,0.6835857361474444,0.8519247163748442,0.3240748829403312,"['CPT2', 'PLIN2']",0.9923797351506365,0,0,2
139,Breast cancer,0.6841354562368447,0.8599242474583029,0.32642668154229626,"['NOTCH2', 'NCOA1', 'FZD3', 'FZD9']",0.9923797351506365,0,0,4
140,Aldosterone-regulated sodium reabsorption,0.6897980207057013,0.8692487479131886,0.3228011273297757,['IRS1'],0.9923797351506365,0,0,1
141,Ether lipid metabolism,0.6897980207057013,0.8692487479131886,0.3228011273297757,['PLPP1'],0.9923797351506365,0,0,1
142,Amphetamine addiction,0.6934881023472221,0.835477231798302,0.30580237505089886,"['PPP3CB', 'CREB5']",0.9923797351506365,0,0,2
143,Endometrial cancer,0.6934881023472221,0.835477231798302,0.30580237505089886,"['CTNNA1', 'CTNNA2']",0.9923797351506365,0,0,2
144,Diabetic cardiomyopathy,0.6940766749608347,0.8623319285570942,0.31490020103437044,"['UQCRB', 'CPT2', 'IRS1', 'GSR', 'PDK3', 'UQCR10']",0.9923797351506365,0,0,6
145,Human immunodeficiency virus 1 infection,0.6940766749608347,0.8623319285570942,0.31490020103437044,"['DDB1', 'PDIA3', 'PPP3CB', 'AP1B1', 'CALR', 'HLA-E']",0.9923797351506365,0,0,6
146,Central carbon metabolism in cancer,0.7031332852281649,0.819650407017101,0.28868809465442524,"['PDGFRB', 'PFKP']",0.9923797351506365,0,0,2
147,Fructose and mannose metabolism,0.703467260525797,0.8357518941826121,0.2939623078553652,['PFKP'],0.9923797351506365,0,0,1
148,Vascular smooth muscle contraction,0.7056189731051619,0.8245658673112397,0.28750953206086133,"['PPP1R12A', 'KCNMB3', 'ADCY8']",0.9923797351506365,0,0,3
149,mRNA surveillance pathway,0.7056189731051619,0.8245658673112397,0.28750953206086133,"['PPP2R1B', 'PPP2R2B', 'PABPC1L']",0.9923797351506365,0,0,3
150,Human cytomegalovirus infection,0.711305200526773,0.8453364817001181,0.287966988376635,"['PDIA3', 'PPP3CB', 'CALR', 'ADCY8', 'HLA-E', 'CREB5']",0.9923797351506365,0,0,6
151,Th1 and Th2 cell differentiation,0.7125247106822382,0.8044097609315001,0.2726471960194105,"['NOTCH2', 'PPP3CB']",0.9923797351506365,0,0,2
152,ABC transporters,0.7165351131335693,0.8047362888765226,0.2682411589820886,['ABCC8'],0.9923797351506365,0,0,1
153,Citrate cycle (TCA cycle),0.7165351131335693,0.8047362888765226,0.2682411589820886,['ACO1'],0.9923797351506365,0,0,1
154,RNA polymerase,0.7165351131335693,0.8047362888765226,0.2682411589820886,['POLR1A'],0.9923797351506365,0,0,1
155,Axon guidance,0.716898411403159,0.8398175301401107,0.2795090227771889,"['ENAH', 'SEMA5B', 'FZD3', 'PPP3CB', 'SEMA3D', 'EPHB2']",0.9923797351506365,0,0,6
156,Pancreatic secretion,0.7216660009506328,0.7897233201581028,0.2576021002645474,"['RAP1A', 'ADCY8']",0.9923797351506365,0,0,2
157,Adrenergic signaling in cardiomyocytes,0.7381664754214831,0.7963179607167047,0.24175090747260936,"['PPP2R1B', 'PPP2R2B', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,4
158,Ras signaling pathway,0.7385198215187826,0.8184359316434788,0.24807393585098886,"['PDGFRB', 'MRAS', 'RAP1A', 'ANGPT2', 'PLCE1', 'RASGRP1']",0.9923797351506365,0,0,6
159,Cardiac muscle contraction,0.7392135051563848,0.76189637974535,0.2302210777347301,"['UQCRB', 'UQCR10']",0.9923797351506365,0,0,2
160,Natural killer cell mediated cytotoxicity,0.747627739162863,0.7487025717910276,0.21776021772959286,"['PPP3CB', 'HLA-E']",0.9923797351506365,0,0,2
161,Taste transduction,0.7523887672920386,0.72409571508069,0.20600675938870444,['ADCY8'],0.9923797351506365,0,0,1
162,Alzheimer disease,0.7547148844839542,0.8389607594634018,0.23609634137824898,"['BACE1', 'PSMD6', 'FZD3', 'PPP3CB', 'UQCRB', 'IRS1', 'FZD9', 'CAPN2', 'ADAM10', 'MAPT', 'UQCR10']",0.9923797351506365,0,0,11
163,SNARE interactions in vesicular transport,0.7633038990677773,0.7006839355915774,0.18925405275429724,['SNAP29'],0.9923797351506365,0,0,1
164,Mitophagy,0.7714828264430339,0.7117166511321893,0.18464838530127148,"['PRKN', 'MRAS']",0.9923797351506365,0,0,2
165,Olfactory transduction,0.7737386358051039,0.6787353923205343,0.1741099781286231,['GRK3'],0.9923797351506365,0,0,1
166,Dilated cardiomyopathy,0.7789864889768296,0.7001834070557773,0.1748789121611888,"['ADCY8', 'ACTG1']",0.9923797351506365,0,0,2
167,Neutrophil extracellular trap formation,0.7789864889768296,0.7001834070557773,0.1748789121611888,"['CLCN4', 'ACTG1']",0.9923797351506365,0,0,2
168,TGF-beta signaling pathway,0.7789864889768296,0.7001834070557773,0.1748789121611888,"['ACVR1C', 'PPP2R1B']",0.9923797351506365,0,0,2
169,"Growth hormone synthesis, secretion and action",0.7823706568078228,0.7231714126186488,0.17748554805473643,"['IRS1', 'ADCY8', 'CREB5']",0.9923797351506365,0,0,3
170,Th17 cell differentiation,0.7862735361001907,0.6890162977119498,0.16567433864112863,"['PPP3CB', 'RORA']",0.9923797351506365,0,0,2
171,Cellular senescence,0.7902622948599174,0.7350699579115004,0.17302838923422512,"['PPP3CB', 'MRAS', 'CAPN2', 'HLA-E']",0.9923797351506365,0,0,4
172,Fatty acid degradation,0.7932504351692651,0.6387115781203967,0.14793601244584825,['CPT2'],0.9923797351506365,0,0,1
173,Homologous recombination,0.7932504351692651,0.6387115781203967,0.14793601244584825,['RAD54B'],0.9923797351506365,0,0,1
174,Legionellosis,0.7932504351692651,0.6387115781203967,0.14793601244584825,['HSPA2'],0.9923797351506365,0,0,1
175,Calcium signaling pathway,0.7994957329384558,0.7422585472545182,0.16609822641771144,"['PDGFRB', 'PPP3CB', 'PLCE1', 'ADCY8', 'PLCD1']",0.9923797351506365,0,0,5
176,Ferroptosis,0.8023669786917392,0.6204149773431911,0.13660867526905912,['FTH1'],0.9923797351506365,0,0,1
177,MicroRNAs in cancer,0.8105978573508799,0.7107492573440423,0.14924540919705262,"['PDGFRB', 'NOTCH2', 'FZD3', 'IRS1']",0.9923797351506365,0,0,4
178,Bile secretion,0.8110821682357172,0.6031348543869411,0.12628794203670654,['ADCY8'],0.9923797351506365,0,0,1
179,Cocaine addiction,0.8110821682357172,0.6031348543869411,0.12628794203670654,['CREB5'],0.9923797351506365,0,0,1
180,Gap junction,0.8133458915310632,0.6476813258124096,0.133810190573062,"['PDGFRB', 'ADCY8']",0.9923797351506365,0,0,2
181,Fluid shear stress and atherosclerosis,0.816782001305461,0.6776591289782244,0.1371467200239922,"['CTSL', 'KLF2', 'ACTG1']",0.9923797351506365,0,0,3
182,Aldosterone synthesis and secretion,0.8196177010434821,0.6381074168797954,0.1269305825739479,"['ADCY8', 'CREB5']",0.9923797351506365,0,0,2
183,C-type lectin receptor signaling pathway,0.8196177010434821,0.6381074168797954,0.1269305825739479,"['PPP3CB', 'MRAS']",0.9923797351506365,0,0,2
184,GABAergic synapse,0.8196177010434821,0.6381074168797954,0.1269305825739479,"['ADCY8', 'SLC38A2']",0.9923797351506365,0,0,2
185,Prostate cancer,0.8257000566717286,0.6288110125539237,0.12043221104846552,"['PDGFRB', 'CREB5']",0.9923797351506365,0,0,2
186,Signaling pathways regulating pluripotency of stem cells,0.8271786405066649,0.6637267972515639,0.12593193639405248,"['FZD3', 'ACVR1C', 'FZD9']",0.9923797351506365,0,0,3
187,Leishmaniasis,0.8273782764490754,0.5713030489412179,0.10825808890216364,['MARCKSL1'],0.9923797351506365,0,0,1
188,T cell receptor signaling pathway,0.8315974575863635,0.6197802197802198,0.11429167479751866,"['PPP3CB', 'RASGRP1']",0.9923797351506365,0,0,2
189,Basal transcription factors,0.8349921891108912,0.556611446427807,0.10037536105722455,['GTF2H3'],0.9923797351506365,0,0,1
190,Other types of O-glycan biosynthesis,0.8349921891108912,0.556611446427807,0.10037536105722455,['GALNT8'],0.9923797351506365,0,0,1
191,Peroxisome,0.8373143740625807,0.6110038155353525,0.10848719963615329,"['NUDT7', 'PEX5L']",0.9923797351506365,0,0,2
192,Neurotrophin signaling pathway,0.8418250858072132,0.6438628787501866,0.11086225679053831,"['RPS6KA3', 'RAP1A', 'IRS1']",0.9923797351506365,0,0,3
193,Endocrine and other factor-regulated calcium reabsorption,0.8492288576511575,0.5293782320127041,0.08651446740377981,['AP2A1'],0.9923797351506365,0,0,1
194,Fanconi anemia pathway,0.8492288576511575,0.5293782320127041,0.08651446740377981,['FANCC'],0.9923797351506365,0,0,1
195,Glycolysis / Gluconeogenesis,0.8492288576511575,0.5293782320127041,0.08651446740377981,['PFKP'],0.9923797351506365,0,0,1
196,Pathways in cancer,0.8519650199281077,0.7713555609637381,0.12357872741556751,"['NOTCH2', 'ALK', 'NCOA1', 'PDGFRB', 'FZD3', 'TXNRD1', 'FZD9', 'GLI1', 'ADCY8', 'RASGRP1', 'MSH2', 'CTNNA1', 'CTNNA2']",0.9923797351506365,0,0,13
197,AGE-RAGE signaling pathway in diabetic complications,0.8534263673106824,0.5860978034891078,0.09289416445227897,"['PLCE1', 'PLCD1']",0.9923797351506365,0,0,2
198,Cytokine-cytokine receptor interaction,0.8584652748383954,0.5782385730211818,0.08824443820781691,"['GDF10', 'ACVR1C']",0.9923797351506365,0,0,2
199,Endocytosis,0.8591329150234587,0.7076011410379663,0.10743623937003731,"['GRK3', 'AP2A1', 'HSPA2', 'VPS45', 'VPS36', 'RAB11FIP4', 'HLA-E']",0.9923797351506365,0,0,7
200,Hepatitis C,0.8596748627548172,0.6191433357262504,0.0936151087073806,"['PPP2R1B', 'PPP2R2B', 'EIF3E']",0.9923797351506365,0,0,3
201,RIG-I-like receptor signaling pathway,0.8622390582499384,0.5046783398687735,0.07480479475191178,['DHX58'],0.9923797351506365,0,0,1
202,Circadian entrainment,0.8633454249844041,0.5705861644076747,0.08384216338713975,"['KCNJ9', 'ADCY8']",0.9923797351506365,0,0,2
203,Viral carcinogenesis,0.8657975618729812,0.6416604523987074,0.09246594050952177,"['DDB1', 'GTF2H3', 'HLA-E', 'CREB5']",0.9923797351506365,0,0,4
204,Yersinia infection,0.8679198764561906,0.6074766355140186,0.08605263544693624,"['RPS6KA3', 'DOCK1', 'ACTG1']",0.9923797351506365,0,0,3
205,"Parathyroid hormone synthesis, secretion and action",0.8680710064665791,0.5631325196542588,0.07967298167352307,"['ADCY8', 'CREB5']",0.9923797351506365,0,0,2
206,PI3K-Akt signaling pathway,0.8709521047420178,0.6944010396522116,0.09594420592890965,"['PDGFRB', 'ANGPT2', 'PPP2R1B', 'IRS1', 'PPP2R2B', 'COL9A2', 'CREB5']",0.9923797351506365,0,0,7
207,Chemokine signaling pathway,0.8718801083545623,0.6018053229108505,0.0825095287947834,"['GRK3', 'RAP1A', 'ADCY8']",0.9923797351506365,0,0,3
208,Fc epsilon RI signaling pathway,0.8741282879127006,0.48217399369319236,0.06486596647249092,['INPP5D'],0.9923797351506365,0,0,1
209,VEGF signaling pathway,0.8796830071710502,0.4716556579806925,0.0604632629470962,['PPP3CB'],0.9923797351506365,0,0,1
210,Long-term depression,0.8849929829038328,0.46158491102191596,0.05639439634311082,['PPP2R1B'],0.9923797351506365,0,0,1
211,Epstein-Barr virus infection,0.8862359070088878,0.6140701604074444,0.07416254471462629,"['PDIA3', 'PSMD6', 'CALR', 'HLA-E']",0.9923797351506365,0,0,4
212,Cholinergic synapse,0.8895225929941507,0.5285912390896484,0.06188237328300986,"['ADCY8', 'CREB5']",0.9923797351506365,0,0,2
213,Retrograde endocannabinoid signaling,0.8901454135768195,0.5749544181082403,0.06690770066239803,"['RIMS1', 'KCNJ9', 'ADCY8']",0.9923797351506365,0,0,3
214,Huntington disease,0.892796900918834,0.6831000961435744,0.0774609268106706,"['DNAH12', 'PSMD6', 'KCNJ10', 'UQCRB', 'AP2A1', 'UQCR10', 'NRF1', 'CREB5']",0.9923797351506365,0,0,8
215,Insulin signaling pathway,0.8935062900020087,0.5698668782509037,0.06416809590155949,"['PYGB', 'IRS1', 'RHOQ']",0.9923797351506365,0,0,3
216,Melanoma,0.8949212960345964,0.44267656979319275,0.04914573231024202,['PDGFRB'],0.9923797351506365,0,0,1
217,HIF-1 signaling pathway,0.8971606319955823,0.5159261028826246,0.05598848437388619,"['ANGPT2', 'PFKP']",0.9923797351506365,0,0,2
218,Prion disease,0.9047916237360918,0.6356704297880769,0.06359921540930373,"['PSMD6', 'PPP3CB', 'UQCRB', 'UQCR10', 'HSPA2', 'CREB5']",0.9923797351506365,0,0,6
219,Salivary secretion,0.9082324075712501,0.41704122255040454,0.04014229355860081,['ADCY8'],0.9923797351506365,0,0,1
220,Adipocytokine signaling pathway,0.9161573197084953,0.4015334198973598,0.03516115031945956,['IRS1'],0.9923797351506365,0,0,1
221,Hepatitis B,0.9198354022188664,0.5278016096743882,0.04410338518286544,"['DDB1', 'HSPG2', 'CREB5']",0.9923797351506365,0,0,3
222,Spinocerebellar ataxia,0.9223615029225055,0.5235046198735613,0.04230862080182818,"['PSMD6', 'RORA', 'PUM2']",0.9923797351506365,0,0,3
223,Hypertrophic cardiomyopathy,0.926781978523308,0.38031221626687756,0.02891777391859282,['ACTG1'],0.9923797351506365,0,0,1
224,Relaxin signaling pathway,0.9284909083169258,0.4606845513413506,0.03418034749015121,"['ADCY8', 'CREB5']",0.9923797351506365,0,0,2
225,Non-alcoholic fatty liver disease,0.9339332703963377,0.5030189708231078,0.03438149166476511,"['UQCRB', 'IRS1', 'UQCR10']",0.9923797351506365,0,0,3
226,Kaposi sarcoma-associated herpesvirus infection,0.9420232989642864,0.48773944912532585,0.029130370875854354,"['PPP3CB', 'ANGPT2', 'HLA-E']",0.9923797351506365,0,0,3
227,Glioma,0.9466349034502245,0.33853297161936563,0.018565754053440204,['PDGFRB'],0.9923797351506365,0,0,1
228,Inflammatory mediator regulation of TRP channels,0.9466349034502245,0.33853297161936563,0.018565754053440204,['ADCY8'],0.9923797351506365,0,0,1
229,Renal cell carcinoma,0.9466349034502245,0.33853297161936563,0.018565754053440204,['RAP1A'],0.9923797351506365,0,0,1
230,Non-small cell lung cancer,0.9489931412949404,0.33329908822396304,0.017449443040068673,['ALK'],0.9923797351506365,0,0,1
231,Serotonergic synapse,0.9489931412949404,0.33329908822396304,0.017449443040068673,['KCNJ9'],0.9923797351506365,0,0,1
232,Salmonella infection,0.9490640480323363,0.5423335163211013,0.02835264990059524,"['CYFIP2', 'DYNC1LI2', 'FLNA', 'ACTG1', 'KPNA1']",0.9923797351506365,0,0,5
233,Lipid and atherosclerosis,0.9491873819160914,0.4733521622712101,0.02468486458238555,"['PPP3CB', 'RAP1A', 'HSPA2']",0.9923797351506365,0,0,3
234,FoxO signaling pathway,0.9506513938671534,0.4160663750964754,0.021056225367564865,"['IRS1', 'KLF2']",0.9923797351506365,0,0,2
235,Influenza A,0.9524659679314686,0.4120719859850295,0.02006827733445102,"['ACTG1', 'KPNA1']",0.9923797351506365,0,0,2
236,Pancreatic cancer,0.9534020481950533,0.32330002740886554,0.015427420778439761,['ARHGEF6'],0.9923797351506365,0,0,1
237,Ribosome biogenesis in eukaryotes,0.9554616828598154,0.31852106451929685,0.014512016472303706,['NAT10'],0.9923797351506365,0,0,1
238,Parkinson disease,0.9557891754070634,0.5288350634371396,0.02391282056969507,"['PRKN', 'PSMD6', 'UQCRB', 'MAPT', 'UQCR10']",0.9923797351506365,0,0,5
239,GnRH signaling pathway,0.9611110552945998,0.3049918878882645,0.012097599143098879,['ADCY8'],0.9923797351506365,0,0,1
240,Amyotrophic lateral sclerosis,0.9623567476464203,0.5779067658262289,0.022174315840822356,"['PRKN', 'DNAH12', 'PSMD6', 'PPP3CB', 'NUP210', 'UQCRB', 'UQCR10', 'ACTG1']",0.9923797351506365,0,0,8
241,Colorectal cancer,0.9675464113256376,0.2886366165831942,0.009522666022518375,['MSH2'],0.9923797351506365,0,0,1
242,Toxoplasmosis,0.9675464113256376,0.2886366165831942,0.009522666022518375,['HSPA2'],0.9923797351506365,0,0,1
243,JAK-STAT signaling pathway,0.9689816755679208,0.28481679992970743,0.008974457153955845,['PDGFRB'],0.9923797351506365,0,0,1
244,Osteoclast differentiation,0.971664862246095,0.277470998673002,0.007975716814761556,['PPP3CB'],0.9923797351506365,0,0,1
245,TNF signaling pathway,0.971664862246095,0.277470998673002,0.007975716814761556,['CREB5'],0.9923797351506365,0,0,1
246,Alcoholism,0.9774020848749977,0.2606553090492186,0.005957840381565631,['CREB5'],0.9923797351506365,0,0,1
247,Spliceosome,0.978644639944281,0.34283590805329933,0.007400690766879288,"['SNRPD1', 'HSPA2']",0.9923797351506365,0,0,2
248,Neuroactive ligand-receptor interaction,0.9794548350743066,0.34011007821346745,0.0070603970978004305,"['GPR35', 'ADORA1']",0.9923797351506365,0,0,2
249,Pathways of neurodegeneration,0.9794641779620894,0.5647636039250669,0.011718626796967951,"['PRKN', 'DNAH12', 'PSMD6', 'FZD3', 'PPP3CB', 'UQCRB', 'FZD9', 'CAPN2', 'MAPT', 'UQCR10']",0.9923797351506365,0,0,10
250,Measles,0.9827767705240337,0.24297049389431824,0.004221193117383517,['HSPA2'],0.9923797351506365,0,0,1
251,Pathogenic Escherichia coli infection,0.9894265966842605,0.29956335934596806,0.0031842683174012273,"['CYFIP2', 'ACTG1']",0.9923797351506365,0,0,2
252,Tuberculosis,0.9899985378494626,0.21390436205557117,0.0021501265989944296,['PPP3CB'],0.9923797351506365,0,0,1
253,NOD-like receptor signaling pathway,0.9923797351506365,0.2018161109637558,0.0015437817282490998,['RNF31'],0.9923797351506365,0,0,1
254,Transcriptional misregulation in cancer,0.9923797351506365,0.2018161109637558,0.0015437817282490998,['ETV1'],0.9923797351506365,0,0,1
